Physician profile
Michael C Soulen
NPI 1447296579
$155,072.64
in general payments reported to CMS, 2019-2025
15 companies · $105K in 2025
The $105K reported for 2025 was more than what 99% of Vascular & Interventional Radiology providers received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $7,393 · 2021: $954 · 2022: $1,221 · 2023: $12K · 2024: $17K · 2025: $105K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $106K · Travel and Lodging: $24K · Food and Beverage: $3,157 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,830.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $105,764.41 |
| Travel and Lodging | $24,192.44 |
| Food and Beverage | $3,156.53 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,830.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Guerbet LLC | $119,692.62 | 2019-2025 | Lipiodol, Lipiodol |
| Instylla, INC. | $8,763.07 | 2024-2025 | Instylla Microcatheter, Instylla Delivery Kit |
| Sirtex Medical INC | $6,659.99 | 2019-2025 | Sir-Spheres Microspheres |
| Astrazeneca Pharmaceuticals Lp | $5,867.95 | 2022-2025 | Imfinzi |
| Siemens Medical Solutions USA, INC. | $5,325.66 | 2021-2023 | |
| Advanced Accelerator Applications | $3,208.00 | 2020 | |
| Genentech USA, INC. | $2,185.00 | 2020 | |
| Cook Incorporated | $1,830.00 | 2023 | Cook |
| Terumo Medical Corporation | $900.00 | 2021 | |
| Trisalus Life Sciences, INC. | $264.00 | 2024-2025 | Trinav Infusion System |
| Delcath Systems | $161.18 | 2025 | Hepzato Kit |
| Abk Biomedical USA, INC. | $122.83 | 2025 | Eye90 Microspheres |
| Boston Scientific Corporation | $92.34 | 2022-2024 | Obsidio |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Soulen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.